Thioredoxin Reductase

Inhibitory Selectivity

Thioredoxin Reductase Products

All (3) Thioredoxin Reductase Inhibitors (3)

Catalog No.	Information	Product Use Citations
S0267^New	TRi-1 TRi-1 is a potent, specific and irreversible cytosolic thioredoxin reductase 1 (TXNRD1) inhibitor with IC50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
S8068	Chaetocin Chaetocin, a natural product from Chaetomium species, is a histone methyltransferase inhibitor with IC50 of 0.8 μM, 2.5 μM and 3 μM for dSU(VAR)3-9, mouse G9a and Neurospora crassa DIM5, respectively. Chaetocin is an anticancer agent and inhibitor of thioredoxin reductase (TrxR).	Nat Commun, 2020, 11(1):4709 Front Endocrinol (Lausanne), 2020, 11:323 Nat Commun, 2019, 10(1):273
S4307^New	Auranofin Auranofin (Ridaura, SKF-39162) is an inhibitor of thioredoxin reductase (TrxR) with IC50 of 88 nM for purified H. pylori TrxR in cell-free assay. Auranofin has anti-cancer activity and can completely inhibit bacterial growth at 1.2 μM. Auranofin is an FDA-approved gold-containing compound used for the treatment of rheumatoid arthritis.	Oncotarget, 2018,

Catalog No.

Information

Product Use Citations

Product Validations

S0267^New

TRi-1

TRi-1 is a potent, specific and irreversible cytosolic thioredoxin reductase 1 (TXNRD1) inhibitor with IC50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.

S8068

Chaetocin, a natural product from Chaetomium species, is a histone methyltransferase inhibitor with IC50 of 0.8 μM, 2.5 μM and 3 μM for dSU(VAR)3-9, mouse G9a and Neurospora crassa DIM5, respectively. Chaetocin is an anticancer agent and inhibitor of thioredoxin reductase (TrxR).

Nat Commun, 2020, 11(1):4709

Front Endocrinol (Lausanne), 2020, 11:323

Nat Commun, 2019, 10(1):273

S4307^New

Auranofin

Auranofin (Ridaura, SKF-39162) is an inhibitor of thioredoxin reductase (TrxR) with IC50 of 88 nM for purified H. pylori TrxR in cell-free assay. Auranofin has anti-cancer activity and can completely inhibit bacterial growth at 1.2 μM. Auranofin is an FDA-approved gold-containing compound used for the treatment of rheumatoid arthritis.

Oncotarget, 2018,

Catalog No.	Information	Product Use Citations
S0267^New	TRi-1 TRi-1 is a potent, specific and irreversible cytosolic thioredoxin reductase 1 (TXNRD1) inhibitor with IC50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.
S8068	Chaetocin Chaetocin, a natural product from Chaetomium species, is a histone methyltransferase inhibitor with IC50 of 0.8 μM, 2.5 μM and 3 μM for dSU(VAR)3-9, mouse G9a and Neurospora crassa DIM5, respectively. Chaetocin is an anticancer agent and inhibitor of thioredoxin reductase (TrxR).	Nat Commun, 2020, 11(1):4709 Front Endocrinol (Lausanne), 2020, 11:323 Nat Commun, 2019, 10(1):273
S4307^New	Auranofin Auranofin (Ridaura, SKF-39162) is an inhibitor of thioredoxin reductase (TrxR) with IC50 of 88 nM for purified H. pylori TrxR in cell-free assay. Auranofin has anti-cancer activity and can completely inhibit bacterial growth at 1.2 μM. Auranofin is an FDA-approved gold-containing compound used for the treatment of rheumatoid arthritis.	Oncotarget, 2018,